SCYNEXIS, Inc. Other Receivables
SCYNEXIS, Inc. (SCYX) had Other Receivables of $0 as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes › and Others
us-gaap:OtherReceivables · last filed 2022-03-29
- 2021-09-30: Other Receivables $0.00.
- 2021-06-30: Other Receivables $0.00.
- 2021-03-31: Other Receivables $1.00M.
- 2020-12-31: Other Receivables $2.88M.
| Period end | Other Receivables |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $2.88M 10-K · filed 2022-03-29 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |